Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Net Income towards Common Stockholders (2013 - 2018)

Updated

Altamira Therapeutics' Net Income towards Common Stockholders came in at -$27.54 million for FY2022, compared with -$33.59 million in FY2021.

Analysis

Altamira Therapeutics (CYTOF) Net Income towards Common Stockholders (2013 - 2018) Analysis & Trends

Going back to FY2015, Altamira Therapeutics' Net Income towards Common Stockholders data covers 8 years.

  • The five-year range for annual Net Income towards Common Stockholders is -$33.59 million (FY2021) to -$6.7 million (FY2019).
  • Per Business Quant, earlier years put Net Income towards Common Stockholders at -$33.59 million in FY2021, -$9.07 million in FY2020, -$6.7 million in FY2019 and -$11.55 million in FY2018.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.72 Mn
Sep 30, 2018 -2.81 Mn
Jun 30, 2018 -2.35 Mn
Mar 31, 2018 -1.53 Mn
Dec 31, 2017 -4.76 Mn
Sep 30, 2017 -6.16 Mn
Jun 30, 2017 -5.40 Mn
Mar 31, 2017 -8.12 Mn
Dec 31, 2016 -5.43 Mn
Sep 30, 2016 -8.06 Mn
Jun 30, 2016 -9.06 Mn
Mar 31, 2016 -9.18 Mn
Dec 31, 2015 -5.39 Mn
Sep 30, 2015 -5.45 Mn
Jun 30, 2015 -11.59 Mn
Mar 31, 2015 -8.68 Mn
Dec 31, 2014 -4.98 Mn
Sep 30, 2014 -3.64 Mn
Jun 30, 2014 -6.59 Mn
Mar 31, 2014 -6.58 Mn
API Access

Altamira Therapeutics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CYTOF&period=max&api_key=YOUR_API_KEY